SELLAS Life Sciences Group, Inc. (RXK3)
FSX
Closed
Oct 9, 2026
Day's Range
9.9252 wk Range
1.20Overview - RXK3 - SELLAS Life Sciences Group, Inc.
Key Statistics
Valuation
Enterprise Value
1.73B
P/E (Trailing)
‪-41.79‬
P/E (Forward)
‪-7.25‬
PEG Ratio
‪1.46‬
Price / Book
‪17.58‬
EV / EBITDA
‪-61.20‬
Profitability
Profit Margin
‪0.00%‬
Operating Margin
‪0.00%‬
Return on Assets
‪-23.29%‬
Return on Equity
‪-39.63%‬
Ownership
Shares Outstanding
201.91M
Float
201.14M
Held by Insiders
‪0.92%‬
Held by Institutions
‪37.00%‬
Price stats
Beta
‪2.52‬
50-Day Avg
‪10.83‬
200-Day Avg
‪6.63‬
Dividends
Payout Ratio
‪0.00%‬
Market Cap - RXK3 - SELLAS Life Sciences Group, Inc.
Peers - RXK3 - SELLAS Life Sciences Group, Inc.
Peer Comparison
Compared with companies in Biotechnology listed on FSX.
- RXK3FSXSELLAS Life Sciences Group, Inc.2.11BMarket Cap+87.00%52-week change-41.80P/E (Trailing)‪0.00%‬Profit Margin
- ANLFSXAnalog Devices Inc.179.11BMarket Cap+43.92%52-week change47.10P/E (Trailing)‪29.78%‬Profit Margin
- 0QFFSXModerna Inc.69.12BMarket Cap+87.76%52-week change25.27P/E (Trailing)‪-141.42%‬Profit Margin
- 64BFSXAstera Labs, Inc.53.43BMarket Cap+42.53%52-week change179.66P/E (Trailing)‪30.74%‬Profit Margin
- 1AEFSXargenx SE52.63BMarket Cap+28.29%52-week change36.62P/E (Trailing)‪32.26%‬Profit Margin
- 1AEAFSXargenx SE American Depositary Receipt50.36BMarket Cap+25.47%52-week change34.88P/E (Trailing)‪32.26%‬Profit Margin
- 42ZFSXRevolution Medicines, Inc.37.58BMarket Cap+78.78%52-week change-29.47P/E (Trailing)‪0.00%‬Profit Margin
Profile Summary - RXK3 - SELLAS Life Sciences Group, Inc.
About
SELLAS Life Sciences Group, Inc. is a late-stage clinical biopharmaceutical company focused on developing novel therapies for cancer. SELLAS Life Sciences Group, Inc. concentrates on immunotherapeutic and targeted oncology programs designed to address a broad range of hematologic and solid tumor indications. Its…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
